Hello guys, Welcome to Africa's Largest Video Search Engine, and you are watching Prognosis and treatment in high-risk MDS. and this video is uploaded by VJHemOnc – Video Journal of Hematology & HemOnc at 2020-03-12T05:53:29-07:00. We are just promoting this video only for entertainment and educational purpose only. I hop you like our Video Search Engine. [y-0jOJ_07mM]
| Name | Prognosis and treatment in high-risk MDS |
| Video Uploader | Video From VJHemOnc – Video Journal of Hematology & HemOnc |
| Upload Date | This Video Uploaded At 12-03-2020 12:53:29 |
| Video Discription | Drorit Merkel, MD, Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel, discusses the unmet need for novel treatments in high-risk myelodysplastic syndromes (MDS), with reference to the advantages and disadvantages of using azacitidine. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel. [y-0jOJ_07mM] |
| Category | Education |
| Tags | Speaker: Drorit Merkel | Institution: Cancer Biology Research Center | Event: MDS 2020 | Format: Interview | Subject: Myelodysplastic Syndromes | Medicines: Azacitidine | Field: Treatment | Field: Clinical Practice | prognosis |
